Skip to main content
Procopio Logo

Procopio Adds Two Life Sciences IP Litigation Partners in Washington, D.C.

Procopio Adds Two Life Sciences IP Litigation Partners in Washington, D.C.

Procopio Adds Two Life Sciences IP Litigation Partners in Washington, D.C.

February 17, 2022 (Washington, DC and San Diego, CA) – Accomplished life sciences patent litigators Steven Maddox and Jeremy Edwards have joined Procopio as Partners. Based in Washington, D.C., Steven and Jeremy have an extensive track record of court victories in patent disputes for pharmaceutical clients and have bolstered Procopio’s IP Litigation team and Life Sciences and Medical Technology practices.

“We jumped at the chance to bring on board Steven Maddox and Jeremy Edwards, two talented and successful patent litigators who are natural fits with our growing service to the life sciences industry,” said Procopio Managing Partner John D. Alessio.

Steven and Jeremy’s many legal successes include earning a complete victory for Amneal Pharmaceuticals over Noven Pharmaceuticals in connection with Amneal’s ANDA for a generic version of the Minivelle® estrogen patch; persuading a unanimous Federal Circuit panel to affirm the decision of the U.S. Patent Trial and Appeal Board that all claims of six patents by Jazz Pharmaceuticals were invalid as obvious, paving the way for Amneal’s bid to market a therapeutic equivalent of Xyrem® for the treatment of narcolepsy; persuading the Federal Circuit to vacate a trial decision rendered against Actavis after being brought on for the appeal; securing a complete victory for Allergan in first-to-file litigation over Beyaz® and Safyral® (Merck and Bayer), persuading a unanimous Federal Circuit panel to reverse and invalidate the patents under the on-sale bar; and scoring a complete non-infringement victory for Watson before the U.S. District Court for the District of Delaware, obtaining a rare, expedited trial culminating in a rare announcement from the bench of the judge’s decision immediately after the close of evidence, before any post-trial briefing.

“We chose Procopio because of its willingness to articulate and commit to long-term strategic investing in life sciences globally, as well as the firm’s focus in providing legal services to small and medium sized companies in the life sciences,” Steven said. “Such companies are where so much of the true innovation in life sciences is happening, and that is where we wanted to be.”

Steven focuses on patent litigation in the life sciences industry, with special expertise in pharmaceutical Hatch Waxman cases and medical devices. While representing life sciences clients, he has received special recognition for his work in generic drugs, biosimilars, drug formulations, large molecules and vaccines. Prior to entering private practice, Steven served as a trial attorney at the United States Department of Justice. He clerked for The Honorable Thomas P. Griesa, former Chief Judge of the United States District Court for the Southern District of New York. He earned his JD from the University of Virginia (Order of the Coif) and an AB from Harvard University (magna cum laude). He is admitted in Washington, D.C., the U.S. Court of Appeals for the Federal Circuit, and the U.S. Supreme Court. He was recognized by Managing IP magazine as an Intellectual Property Life Sciences star.

“This move is so attractive because it is an opportunity to pursue our shared vision on more than one front,” Jeremy said. “Not only are we excited to establish and expand Procopio’s presence in Washington, D.C., we are thrilled about the prospect of collaborating with the excellent lawyers at Procopio to expand our collective offerings to life sciences clients.”

Jeremy has represented numerous parties in patent litigation spanning a variety of fields, from biotechnology to optics. With extensive experience in life sciences patent litigation, Jeremy has special expertise in pharmaceutical patent litigation brought under the Hatch Waxman Act. Jeremy holds a JD from the University of Maryland School of Law (with Honors) and a BS in Biology from the University of Maryland (University Honors, Departmental Honors, and Phi Beta Kappa). He is admitted in Washington, D.C., Maryland, the U.S. Court of Appeals for the Federal Circuit, the U.S. District Courts for the District of Columbia and the District of Maryland, and before the U.S. Patent and Trademark Office. He has been recognized multiple times by Super Lawyers® as a Washington, D.C., Rising Star in Intellectual Property Litigation.

Steven and Jeremy co-founded Maddox Edwards in Washington, D.C., in 2015, after being Partners at Knobbe Martens. The addition of Steven and Jeremy, as well as paralegal and office manager Tina Priestly, establishes a presence for Procopio in Washington, D.C. The firm has offices in downtown San Diego, Del Mar Heights, Orange County, Silicon Valley, Las Vegas and Scottsdale, and expects to officially open its Washington, D.C. office later this year.

Steven Maddox, Partner
Jeremy Edwards, Partner

Stay up-to-date with the Procopio newsletter.

Sign Up Now


Patrick Ross, Senior Manager of Marketing & Communications
EmailP: 619.906.5740


Suzie Jayyusi, Events Planner
EmailP: 619.525.3818